Covered recipient · General Payments record
ALEXIS C PERKINS
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$6,412.83
- Reported across 159 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $984.62 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $395.79 | 11 |
| E.R. Squibb & Sons, L.L.C. | $139.90 | 2 |
| Regeneron Healthcare Solutions, Inc. | $108.75 | 1 |
| Lilly USA, LLC | $88.67 | 3 |
| Incyte Corporation | $80.16 | 3 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $46.07 | 1 |
| Arcutis Biotherapeutics, Inc. | $43.95 | 2 |
| PFIZER INC. | $43.00 | 1 |
| Dermavant Sciences, Inc. | $23.71 | 1 |
| Amgen Inc. | $14.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.75 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105240439 | CMS |
| ABBVIE INC. | $103.08 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105240443 | CMS |
| ABBVIE INC. | $23.92 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105240447 | CMS |
| ABBVIE INC. | $22.52 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105240451 | CMS |
| ABBVIE INC. | $32.15 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105240455 | CMS |
| ABBVIE INC. | $4.14 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105240459 | CMS |
| ABBVIE INC. | $16.24 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105240463 | CMS |
| ABBVIE INC. | $112.19 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105240467 | CMS |
| ABBVIE INC. | $30.22 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105240471 | CMS |
| ABBVIE INC. | $7.11 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105240475 | CMS |
| ABBVIE INC. | $34.47 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105240479 | CMS |
| Amgen Inc. | $14.62 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117351793 | CMS |
| Arcutis Biotherapeutics, Inc. | $22.45 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121033548 | CMS |
| Arcutis Biotherapeutics, Inc. | $21.50 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121033546 | CMS |
| Dermavant Sciences, Inc. | $23.71 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127917482 | CMS |
| E.R. Squibb & Sons, L.L.C. | $26.63 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101381540 | CMS |
| E.R. Squibb & Sons, L.L.C. | $113.27 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101381548 | CMS |
| Incyte Corporation | $21.13 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141240365 | CMS |
| Incyte Corporation | $29.21 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141224390 | CMS |
| Incyte Corporation | $29.82 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141302543 | CMS |
| Lilly USA, LLC | $32.02 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136025516 | CMS |
| Lilly USA, LLC | $29.19 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136025512 | CMS |
| Lilly USA, LLC | $27.46 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136022724 | CMS |
| PFIZER INC. | $43.00 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131202117 | CMS |
| Regeneron Healthcare Solutions, Inc. | $108.75 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114135844 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $46.07 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152122420 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.